Evidence that conformational changes upon the transition of the native to the modified form of vitronectin are not limited to the heparin binding domain

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1970 • 253,849 citations

Antibodies, a laboratory manual

1989 • 12,929 citations

Plasminogen Activators, Tissue Degradation, and Cancer

1985 • 2,584 citations

Identification of the urokinase receptor as an adhesion receptor for vitronectin.

1994 • 593 citations

Novel purification of vitronectin from human plasma by heparin affinity chromatography.

1988 • 525 citations

Structure and Biological Role of Vitronectin

1991 • 477 citations

Progress in Hemostasis and Thrombosis.

1974 • 349 citations

Characterization of human S protein, an inhibitor of the membrane attack complex of complement. Demonstration of a free reactive thiol group

1985 • 212 citations

Evidence that type 1 plasminogen activator inhibitor binds to the somatomedin B domain of vitronectin.

1991 • 157 citations

Multimeric vitronectin. Identification and characterization of conformation-dependent self-association of the adhesive protein.

1993 • 155 citations

Interaction of vitronectin with collagen.

1986 • 146 citations

Mapping of binding sites for heparin, plasminogen activator inhibitor-1, and plasminogen to vitronectin's heparin-binding region reveals a novel vitronectin-dependent feedback mechanism for the control of plasmin formation.

1992 • 140 citations

The somatomedin B domain of vitronectin. Structural requirements for the binding and stabilization of active type 1 plasminogen activator inhibitor.

1994 • 126 citations

Progress in Hemostasis and Thrombosis.

1979 • 108 citations

The alpha v beta 5 integrin receptor regulates receptor-mediated endocytosis of vitronectin

1993 • 94 citations

Kinetics of inactivation of alpha-thrombin by plasminogen activator inhibitor-1. Comparison of the effects of native and urea-treated forms of vitronectin

1993 • 91 citations

Vitronectin exists in two structurally and functionally distinct forms in human plasma

1989 • 91 citations

Conformational states of vitronectin: preferential expression of an antigenic epitope when vitronectin is covalently and noncovalently complexed with thrombin-antithrombin III or treated with urea

1988 • 89 citations

Serum-derived vitronectin influences the pericellular distribution of type 1 plasminogen activator inhibitor.

1990 • 86 citations

Heparin-binding properties of vitronectin are linked to complex formation as illustrated by in vitro polymerization and binding to the terminal complement complex

1992 • 72 citations

Alteration of vitronectin. Characterization of changes induced by treatment with urea.

1993 • 70 citations

Conformational states of vitronectin: preferential expression of an antigenic epitope when vitronectin is covalently and noncovalently complexed with thrombin-antithrombin III or treated with urea

1988 • 69 citations

Binding of vitronectin-thrombin-antithrombin III complex to human endothelial cells is mediated by the heparin binding site of vitronectin.

1992 • 63 citations

Clustering of vitronectin and RGD peptides on microspheres leads to engagement of integrins on the luminal aspect of endothelial cell membrane

1994 • 62 citations

Receptor-mediated endocytosis of vitronectin is regulated by its conformational state

1993 • 57 citations

Plasmin cleavage of vitronectin Identification of the site and consequent attenuation in binding plasminogen activator inhibitor‐1

1991 • 52 citations

Sulfation of two tyrosine‐residues in human complement S‐protein (vitronectin)

1989 • 45 citations

Synthetic peptides derived from the sequence around the plasmin cleavage site in vitronectin

1993 • 44 citations

A novel β-endorphin binding protein

1989 • 40 citations

Relative topography of biologically active domains of human vitronectin. Evidence from monoclonal antibody epitope and denaturation studies.

1994 • 31 citations

A 30 kD Sulfated Extracellular Matrix Protein Immunologically Crossreactive with Vitronectin

1993 • 20 citations